One Line Pitch: Sam Plas Co is developing a Cold Atmospheric Plasma (CAP) technology to treat several dermatological conditions such as acute and chronic wounds, skin cancers, and post surgical wound closures
Business Summary: The Company was originally founded in Iran in 2020 and planning to relocate to Winnipeg. The company will continue to prototype and develop the product in Iran while awaiting the relocation to Winnipeg where the verification, validation, and clinical evaluation will take place. The company plans to manufacture the product in Canada, where they will obtain regulatory approval from the Food and Drug Administration (FDA) for the USA, Health Canada, and CE Mark. The first clinical application will be for veterinary dermatological wounds then seek progressive indications for human dermatological skin conditions. The company is currently investigating the ideal business model for the product and is considering opening and operating dermatology clinics or sell directly to vet clinics and large hospitals
Sector: Life Sciences